Prinoc is a new and clinically proven topical anti-acne treatment with none of the side effects associated with antibiotic treatment.
(PRWEB) May 6, 2010 -- Acne is a physically and emotionally debilitating disorder, affecting as many as 85% of 11-30 year olds at some stage. Acne does not discriminate. Both males and females alike, teenagers, adults and every ethnic group suffer.
Problems exist with most of the acne treatments options available at the market today. Antibiotics are not as useful as they once were as Propionibacterium acnes (P. acnes), the bacteria most commonly associated with acne, has developed resistance to many antibiotics.
Prinoc is a new and clinically proven topical anti-acne treatment with none of the side effects associated with antibiotic treatment (resistance and sensitisation) and represents a major step forward in the important battle against acne and bacterial resistance.The new substance can be used as first line treatment for skin and soft tissue infections that previously could only be treated with antibiotics.
Developed by a Danish food microbiologist, Lars Pedersen, Prinoc is a patent pending anti-microbial gel which works by supporting the body’s own immune system in destroying gram positive and gram negative bacteria which cause pimples and spots.
Prinoc combines an enzyme lysozyme (which is found naturally) in tears, with antibodies extracted from bovine colustrum, (the very first milk produced after calving), which are a rich source of antibodies. This unique combination is powerful in combating acne-causing bacteria.
Prinoc “All-In-One” Gel 50 ml tube is available at http://www.prinoc.com priced EUR 19 excl. VAT and freight.
About ”Prinoc Company”
I’m a one-man entrepreneur establishing my company on the vision that it must be possible to treat and fight acne without using a huge range of anti-acne products. Prinoc “All-In-One” Gel is a skincare product that helps these who suffer from acne and produced based on nature's own ingredients.
# # #
Read the full story at http://www.prweb.com/releases/2010/05/prweb3963514.htm.
Copyright©2010 Vocus, Inc.
All rights reserved